Skip to main content

Advertisement

Log in

A case of primary diffuse leptomeningeal gliomatosis

  • Case Report
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Primary diffuse leptomeningeal gliomatosis (PDLG) is a rare and fatal disease characterized by diffuse infiltration of the leptomeninges by neoplastic glial cells without evidence of tumor in the brain parenchyma or spinal cord. We report a 60-year-old man with PDLG. He suffered transient right hemiparesis and generalized seizures. MRI showed diffuse leptomeningeal thickening and enhancement throughout the brain and spinal cord without any intraaxial involvement. Biopsy resulted in a diagnosis of glioblastoma with methylated MGMT promoter and wild-type IDH1. He underwent craniospinal radiotherapy and temozolomide treatment but despite concomitant adjuvant therapy he died 8 months after initial presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas: incidence, diagnosis and outcome. Acta Neurochir (Wien) 126:84–92

    Article  CAS  Google Scholar 

  2. Erlich SS, Davis RL (1978) Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42:2854–2864

    Article  CAS  PubMed  Google Scholar 

  3. Onda K, Tanaka R, Takahashi H et al (1989) Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25:533–540

    Article  CAS  PubMed  Google Scholar 

  4. Parsa AT, Wachhorst S, Lamborn KR et al (2005) Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102:622–628

    Article  PubMed  Google Scholar 

  5. Esteller M, Garcia-Foncillas J, Andion E et al (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350–1354

    Article  CAS  PubMed  Google Scholar 

  6. Cooper IS, Kernohan JW (1951) Heterotropic glial nests in the subarachnoid space: histopathologic characteristics, mode of origin and relation to meningeal gliomas. J Neuropathol Exp Neurol 10:16–29

    Article  CAS  PubMed  Google Scholar 

  7. Yomo S, Tada T, Hirayama S et al (2007) A case report and review of the literature. J Neurooncol 81:209–216

    Article  PubMed  Google Scholar 

  8. Baborie A, Dunn EM, Bridges LR et al (2001) Primary diffuse leptomeningeal gliomatosis predominantly affecting the spinal cord: case report and review of the literature. J Neurol Neurosurg Psychiatry 70:256–258

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Corsten LA, Raja AI, Wagner FC Jr (2001) Primary diffuse leptomeningeal gliomatosis. Br J Neurosurg 15:62–66

    Article  CAS  PubMed  Google Scholar 

  10. Arita H, Narita Y, Fukushima S et al (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267–276

    Article  CAS  PubMed  Google Scholar 

  11. Killela PJ, Reitman ZJ, Jiao Y et al (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110(15):6021–6026

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Nonoguchi N, Ohta T, Oh JE et al (2013) TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol 126:931–937

    Article  CAS  PubMed  Google Scholar 

  13. Bohner G, Masuhr F, Distl R (2005) Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature. Acta Neuropathol (Berl) 110(3):306–311

    Article  Google Scholar 

  14. Izumoto S, Ohnishi T, Kenemura H (2001) PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis. J Neurooncol 53(1):21–26

    Article  CAS  PubMed  Google Scholar 

  15. Franceschi E, Cavallo G, Scopece L (2005) Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis. J Neurooncol 73(3):261–264

    Article  PubMed  Google Scholar 

  16. Hansen N, Wittig A, Hense J (2011) Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review. Eur J Med Res 16(9):415–419

    Article  PubMed Central  PubMed  Google Scholar 

  17. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kouji Yamasaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamasaki, K., Yokogami, K., Ohta, H. et al. A case of primary diffuse leptomeningeal gliomatosis. Brain Tumor Pathol 31, 177–181 (2014). https://doi.org/10.1007/s10014-014-0176-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-014-0176-2

Keywords

Navigation